Peptides for Menopause
The peptides people most often research for menopause, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 8
- With human trials
- 0
- FDA approved (any use)
- 3
- SermorelinGHRH analogNo study with an outcome for menopausePubMed search, 11 Oct 2026Human0Animal0Summarised0Compounded by prescriptionFor menopauseOverview
- TirzepatideGLP-1 / GIP dual agonistNo study with an outcome for menopausePubMed search, 2 Oct 2026Human8Animal7Summarised0FDA approved (Mounjaro, Zepbound)For menopauseOverview
- IpamorelinGHRP (ghrelin receptor agonist)No study with an outcome for menopausePubMed search, 11 Oct 2026Human0Animal0Summarised0Not FDA approved · research chemicalFor menopauseOverview
- hCGGonadotropinNo study with an outcome for menopausePubMed search, 11 Oct 2026Human258Animal15Summarised0FDA approved (prescription only)Overview
- Kisspeptin-10GnRH stimulatorNo study with an outcome for menopausePubMed search, 11 Oct 2026Human3Animal1Summarised0Not FDA approved · research chemicalFor menopauseOverview
- BPC-157Gastric pentadecapeptideNo study with an outcome for menopausePubMed search, 11 Oct 2026Human0Animal0Summarised0PCAC voted 8–6 for 503A (Jul 2026)Overview
- MOTS-cMitochondrial-derived peptideAnimal evidence, 2 of 4Journal of molecular medicine 2019, PMID 30725119Human1Animal0Summarised2PCAC voted 7–5 for 503A (Jul 2026)For menopauseOverview
- HGHRecombinant growth hormoneNo study with an outcome for menopausePubMed search, 2 Oct 2026Human61Animal1Summarised0FDA approved (prescription only)Overview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What menopause is
MedlinePlus says you have reached menopause when you have not had a period for 12 months.[59]
It also says the most common age for reaching menopause is between 45 and 55.[59]
Human versus animal evidence for menopause
In the site's PubMed ledger for menopause (2 Oct 2026), hCG has 258 human-only and 15 animal-only records and growth hormone 61 and 1. Sermorelin, ipamorelin and BPC-157 have none. The counts include papers that only mention menopause.
Calculated from goal menopause; ledger date 2026-10-02; counts sermorelin (human only 0, animal 0, rct 0), tirzepatide (human only 8, animal 7, rct 0), ipamorelin (human only 0, animal 0, rct 0), hcg (human only 258, animal 15, rct 8), kisspeptin (human only 3, animal 1, rct 0), bpc-157 (human only 0, animal 0, rct 0), mots-c (human only 1, animal 0, rct 0), hgh (human only 61, animal 1, rct 24). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).
The most menopause-specific data are mouse work: MOTS-c treatment prevented obesity and insulin resistance after ovariectomy.[1]
In ovariectomized mice, MOTS-c treatment significantly alleviated bone loss on micro-CT.[60]
What FDA labelling says about menopause and peptides
The Vyleesi (bremelanotide, PT-141) label states it is not indicated for the treatment of HSDD in postmenopausal women or in men.[61]
Common questions
What peptides help with menopause symptoms?
No human trial of a listed peptide for menopause symptoms was found; the menopause-relevant results are MOTS-c mouse studies in ovariectomized animals.[1]
Is there an FDA-approved peptide for menopausal women's sex drive?
Not in the cached labels: the Vyleesi label excludes postmenopausal women from its indication.[61]
Does MOTS-c work for menopause in women?
There is no human menopause data for MOTS-c; the evidence is the mouse studies of obesity and bone loss after ovary removal.[60]
Explore nearby goals
Sources
- 1MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.Journal of molecular medicine (Berlin, Germany) · 2019PMID 30725119Accessed 2 Oct 2026
- 2PubMed search: (sermorelin[tiab] OR Geref[tiab]) (34 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: (sermorelin[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab] OR "GHRH 1-29"[tiab]) AND (elderly[tiab] OR aging[tiab] OR "older adults"[tiab] OR adults[tiab]) AND (treatment[tiab] OR therapy[tiab] OR administration[tiab]) (15 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: (sermorelin[tiab] OR Geref[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 12PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 13PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 14PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 15PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 16PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 17PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 18PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 19PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 20PubMed search: ipamorelin[tiab] (50 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 21PubMed search: ipamorelin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 22PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR "male infertility"[tiab] OR hypogonadotropic[tiab] OR testosterone[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (97 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 23PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (obesity[tiab] OR "weight loss"[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt] OR systematic review[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 24PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (testosterone replacement[tiab] OR TRT[tiab] OR "anabolic steroid"[tiab] OR bodybuilder*[tiab] OR "lean body mass"[tiab] OR "muscle"[tiab]) AND humans[mh] (260 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 25PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND men[tiab] NOT pregnan*[tiab] (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 26PubMed search: ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]) AND humans[mh] (110 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 27PubMed search: (kisspeptin[tiab]) AND humans[mh] AND (randomized controlled trial[pt] OR clinical trial[pt]) (54 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 28PubMed search: kisspeptin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND humans[mh] (13 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 29PubMed search: kisspeptin[tiab] AND humans[mh] AND (men[tiab] OR male[tiab]) AND (testosterone[tiab] OR hypogonadism[tiab]) (90 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 30PubMed search: kisspeptin[tiab] AND (menopaus*[tiab] OR postmenopaus*[tiab]) (89 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 31PubMed search: kisspeptin[tiab] AND (liver[tiab] OR NAFLD[tiab] OR hepatic[tiab]) (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 32PubMed search: "BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab] (230 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 33PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 34PubMed search: "BPC-157"[tiab] AND humans[mh] (52 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 35PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (patients[tiab] OR clinical trial[pt] OR randomized[tiab]) (25 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 36PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (colitis[tiab] OR inflammatory bowel[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 37PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (tendon[tiab] OR ligament[tiab] OR muscle[tiab] OR bone[tiab] OR arthritis[tiab]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 38PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (nerve[tiab] OR neuropath*[tiab] OR spinal[tiab] OR liver[tiab] OR wound[tiab] OR burn[tiab]) (90 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 39PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt]) (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 40PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND ("growth hormone deficiency"[tiab]) AND adult*[tiab] AND randomized controlled trial[pt] (66 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 41PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (elderly[tiab] OR "older adults"[tiab] OR healthy[tiab]) AND (systematic review[pt] OR meta-analysis[pt]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 42PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (athlet*[tiab] OR "physical performance"[tiab] OR "recreational"[tiab]) AND (randomized controlled trial[pt] OR systematic review[pt]) (20 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 43PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND sleep[tiab] AND (randomized controlled trial[pt] OR clinical trial[pt]) (12 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 44PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (tendon[tiab] OR collagen[tiab] OR "wound healing"[tiab] OR fracture[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt] OR meta-analysis[pt]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 45PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (cardiovascular[tiab] OR cardiac[tiab] OR "blood pressure"[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]) (77 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 46PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (diabetes[tiab] OR "insulin resistance"[tiab] OR glucose[tiab]) AND adult*[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]) (52 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 47PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND (skin[tiab] OR hair[tiab] OR aging[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (30 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 48PubMed search: (somatropin[tiab] OR "recombinant human growth hormone"[tiab] OR rhGH[tiab] OR "growth hormone replacement"[tiab] OR "growth hormone treatment"[tiab] OR "growth hormone therapy"[tiab]) AND ("sexual function"[tiab] OR libido[tiab] OR "erectile"[tiab] OR "quality of life"[tiab]) AND adult*[tiab] AND (randomized controlled trial[pt] OR meta-analysis[pt]) (29 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 49PubMed search: (sermorelin[tiab] OR Geref[tiab] OR "GHRH(1-29)"[tiab] OR "GRF(1-29)"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 50PubMed search: ipamorelin[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 51PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab] OR cryptorchidism[tiab] OR "male infertility"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) AND humans[mh] (130 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 52PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND ("weight loss"[tiab] OR obesity[tiab] OR cryptorchidism[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR thromboembol*[tiab] OR "case report"[pt] OR death[tiab]) (61 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 53PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (gynecomastia[tiab] OR "injection site"[tiab] OR hypersensitivity[tiab] OR anaphyla*[tiab]) AND (male[tiab] OR men[tiab] OR boys[tiab]) (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 54PubMed search: ("kisspeptin-10"[tiab] OR "kisspeptin-54"[tiab] OR kisspeptin[tiab]) AND humans[mh] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (75 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 55PubMed search: (kisspeptin[tiab]) AND (nausea[tiab] OR flush*[tiab] OR "injection site"[tiab] OR headache[tiab] OR "ovarian hyperstimulation"[tiab] OR tachyphylaxis[tiab] OR desensiti*[tiab]) AND humans[mh] (60 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 56PubMed search: (kisspeptin[tiab] OR "kisspeptin-54"[tiab] OR "kisspeptin-10"[tiab]) AND ("clinical trial"[pt] OR "randomized controlled trial"[pt]) AND (women[tiab] OR men[tiab]) AND (adverse[tiab] OR tolerat*[tiab] OR "side effects"[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 57PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (57 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 58PubMed search: ("BPC-157"[tiab] OR "BPC 157"[tiab]) AND (human[tiab] OR patient*[tiab] OR volunteer*[tiab]) AND (adverse[tiab] OR safety[tiab] OR "side effects"[tiab]) (19 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 59Official web pageOfficial web page · web page
- 60Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation.Biochemical and biophysical research communications · 2016PMID 27237975Accessed 2 Oct 2026
- 61VYLEESI prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.